We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details of the council's committees and latest meeting minutes.
The Home Office is looking for 16 new members to join the Advisory Council on the Misuse of Drugs (ACMD).
Letter commissioning the Advisory Council on the Misuse of Drugs (ACMD) to work on a project to prevent drug use in children and young people.
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) regarding electronic prescribing of controlled drugs proposal from NHS England.
This report provides an updated assessment of the health and social harms of nitrous oxide.
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the harms of Xylazine and 2-Methyl-AP-237.
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of Cumyl-PeGaClone.
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of diphenidine and other related substances.
The government commissions the ACMD to conduct an updated harms assessment of synthetic cathinones.
The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide.
The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the classification and schedule of remimazolam (Byfavo).
Letter from the ACMD Nitrous Oxide working group to collect written evidence about the health and social harms of nitrous oxide.
Letter to the chair of the ACMD asking the council to conduct an updated assessment of the health and social harms of nitrous oxide.
Recommendations to reduce barriers to research, using compounds described by the third generation synthetic cannabinoid receptor agonists generic definition.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) on young people’s drug use.
This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.
The government’s response to the ACMD’s fentanyl report.
Report from the Advisory Council on the Misuse of Drugs (ACMD) on the classification and schedule of Remimazolam.
Letter to the chair of the ACMD inviting them to establish a working group to respond to the recent white paper on drug possession.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.